Famotidine Injection, Solution
Product Images NDC 25021-754

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 25021-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fam0b 0000 01)

Structural Formula (Fam0b 0000 01)
Chemical structure of famotidine, the active ingredient in the famotidine injection solution product by Sagent Pharmaceuticals.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fam0b 0000 02)

Package Label – Principal Display Panel – Vial Label (Fam0b 0000 02)
Label for Famotidine Injection, USP 20 mg per 2 mL (10 mg per mL) single-dose vial. The solution is for intravenous use only after dilution. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India. Includes NDC 25021-753-02 and barcode.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fam0b 0000 03)

Package Label – Principal Display Panel – Vial Label (Fam0b 0000 03)
Famotidine Injection, USP 40 mg per 4 mL (10 mg per mL) intravenous solution in a 4 mL two-dose vial. Label states it is for intravenous use only and after dilution. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fam0b 0000 04)

Package Label – Principal Display Panel – Vial Label (Fam0b 0000 04)
Famotidine Injection, USP 200 mg per 20 mL (10 mg per mL) in a 20 mL multi-dose vial label. The label states it is for preparation of intravenous solutions and intravenous use only after dilution. It is a sterile, nonpyrogenic solution manufactured by Sagent Pharmaceuticals, Schaumburg, IL, made in India. Storage instructions and ingredient details including L-aspartic acid are also noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.